Literature DB >> 33132036

Clinical spectrum and treatment outcome of 95 children with continuous spikes and waves during sleep (CSWS).

Benedikt Sonnek1, Jan Henje Döring1, Ulrike Mütze2, Susanne Schubert-Bast3, Thomas Bast4, Doreen Balke1, Gitta Reuner5, Elisabeth Schuler2, Annick Klabunde-Cherwon1, Georg F Hoffmann6, Stefan Kölker2, Steffen Syrbe7.   

Abstract

OBJECTIVE: Continuous spikes and waves during sleep (CSWS) is an epileptic encephalopathy characterized by generalised epileptiform activity and neurocognitive dysfunction. Causes and outcome are diverse and treatment is mainly empirical.
METHODS: Retrospective descriptive analysis of clinical and EEG data of children with CSWS diagnosed between 1998 and 2018 at the University Hospital Heidelberg.
RESULTS: Ninety-five children were included with a median age at diagnosis of 5.4 years. A structural/metabolic aetiology was found in 43.2%, genetic alterations in 17.9%, while it remained unknown in 38.9%. The proportion of patients with genetic aetiology increased from 10.3% (1998-2007) to 22.8% (2008-2018). On average, each patient received 5 different treatments. CSWS was refractory in >70% of cases, steroids and neurosurgery were most effective. No difference was observed between children with CSWS or Near-CSWS (Spike-Wave-Index 40-85%).
CONCLUSIONS: Our cohort confirms CSWS as an age-dependent epileptic encephalopathy. Structural brain abnormalities were most frequent, but genetic causes are increasingly identified. More specific criteria for the diagnosis and treatment goals should be elaborated and implemented based on evidence. SIGNIFICANCE: This study is the largest monocentric observational study on treatment effects in children with CSWS, providing data for diagnostic and therapeutic decisions.
Copyright © 2020 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CSWS; Continuous spikes and waves during sleep; ESES; Electrical status epilepticus during slow sleep; Epilepsy; Epileptic encephalopathy

Mesh:

Year:  2020        PMID: 33132036     DOI: 10.1016/j.ejpn.2020.10.010

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  1 in total

1.  Complementing the phenotypical spectrum of TUBA1A tubulinopathy and its role in early-onset epilepsies.

Authors:  Inga Harting; Steffen Syrbe; Julian Schröter; Bernt Popp; Heiko Brennenstuhl; Jan H Döring; Stephany H Donze; Emilia K Bijlsma; Arie van Haeringen; Dagmar Huhle; Leonie Jestaedt; Andreas Merkenschlager; Maria Arelin; Daniel Gräfe; Sonja Neuser; Stephanie Oates; Deb K Pal; Michael J Parker; Johannes R Lemke; Georg F Hoffmann; Stefan Kölker
Journal:  Eur J Hum Genet       Date:  2022-01-11       Impact factor: 4.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.